Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisxand Lewisx
- 8 June 1999
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 96 (12) , 6953-6958
- https://doi.org/10.1073/pnas.96.12.6953
Abstract
MAbs against tumor-associated carbohydrate antigens have the potential to play a prominent role in cancer immunotherapy. However, it has not been possible to fully exploit the clinical utility of such antibodies primarily, because those of adequate affinity could be derived only from murine sources. To address this problem, we prepared a single-chain Fv (scFv) antibody library from the peripheral blood lymphocytes of 20 patients with various cancer diseases. Completely human high-affinity scFv antibodies were then selected by using synthetic sialyl Lewisx and Lewisx BSA conjugates. These human scFv antibodies were specific for sialyl Lewisx and Lewisx, as demonstrated by ELISA, BIAcore, and flow cytometry binding to the cell surface of pancreatic adenocarcinoma cells. Nucleotide sequencing revealed that at least four unique scFv genes were obtained. The Kd values ranged from 1.1 to 6.2 × 10−7 M that were comparable to the affinities of mAbs derived from the secondary immune response. These antibodies could be valuable reagents for probing the structure and function of carbohydrate antigens and in the treatment of human tumor diseases.Keywords
This publication has 46 references indexed in Scilit:
- Anti-murine Antibody Response to Mouse Monoclonal Antibodies in Cancer PatientsJapanese Journal of Cancer Research, 1997
- High expression of a Lewis(x)-related epitope in gastric carcinomas indicates metastatic potential and poor prognosisGastroenterology, 1996
- Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display LibraryNature Biotechnology, 1996
- Human Tumor-Associated Lea-Lex Hybrid Carbohydrate Antigen IV3(Gal.beta.1.fwdarw.3[Fuc.alpha.1.fwdarw.4]GlcNAc)III3FucnLc4 Defined by Monoclonal Antibody 43-9F: Enzymic Synthesis, Structural Characterization, and Comparative Reactivity with Various AntibodiesBiochemistry, 1994
- Cellular Mucins: Targets for ImmunotherapyCritical Reviews in Immunology, 1994
- Tumor Antigens Known to be Immunogenic in ManAnnals of the New York Academy of Sciences, 1993
- Antibody framework residues affecting the conformation of the hypervariable loopsJournal of Molecular Biology, 1992
- A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding propertiesMolecular Immunology, 1991
- Reshaping human antibodies for therapyNature, 1988
- GlycosphingolipidsScientific American, 1986